⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL667825 | 1.00 | HIF1A (0.53) | — | |
| SCHEMBL6449707 | 1.00 | HIF1A (0.53) | — | |
| SCHEMBL1682912 | 1.00 | HIF1A (0.53) | — | |
| SCHEMBL1960837 | 1.00 | HIF1A (0.53) | — | |
| SCHEMBL8812128 | 1.00 | HIF1A (0.53) | — | |
| SCHEMBL666947 | 1.00 | HIF1A (0.53) | — | |
| SCHEMBL8812193 | 1.00 | HIF1A (0.53) | — | |
| SCHEMBL98074 | 1.00 | — | — | |
| SCHEMBL21272039 | 1.00 | HIF1A (0.53) | — | |
| SCHEMBL8812609 | 1.00 | HIF1A (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 553 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11965039-B2 | Compstatin analogues and their medical uses | ZP SPV 3 K/S (DK) | 2024-04-23 | — | — | US | claimed |
| US-11851468-B2 | Treatment of neurological diseases | UNIVERSITY OF LANCASTER (GB) | 2023-12-26 | — | — | US | claimed |
| EP-4272751-A2 | COMPSTATIN ANALOGUES AND THEIR MEDICAL USES | ZP SPV 3 K/S (DK) | 2023-11-08 | — | — | EP | claimed |
| US-20230192770-A1 | COMPSTATIN ANALOGUES AND THEIR MEDICAL USES | ZEALAND PHARMA A/S (DK) | 2023-06-22 | — | — | US | claimed |
| US-11382956-B2 | Amylin analogues | ZEALAND PHARMA A/S (DK) | 2022-07-12 | — | — | US | claimed |
| EP-4021921-A1 | COMPSTATIN ANALOGUES AND THEIR MEDICAL USES | ZP SPV 3 K/S (DK) | 2022-07-06 | — | — | EP | claimed |
| CN-114630836-A | Compstatin analogs and medical uses thereof | 西兰制药第三特殊目的公司 | 2022-06-14 | — | — | CN | claimed |
| US-11268110-B2 | Methods and materials for the enzymatic conversion of a non-3-enal to azelaic acid | INV NYLON CHEMICALS AMERICAS, LLC (US) | 2022-03-08 | — | — | US | claimed |
| US-20220033457-A1 | TREATMENT OF NEUROLOGICAL DISEASES | UNIVERSITY OF LANCASTER (GB) | 2022-02-03 | — | — | US | claimed |
| EP-3510044-B1 | AMYLIN ANALOGUES | ZEALAND PHARMA AS (DK) | 2021-11-24 | — | — | EP | claimed |
| WO-1998002741-A1 | QUINOLINE DERIVATIVES AND QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-01-22 | — | — | WO | claimed |
| JP-H09501913-A | — | — | 1997-02-25 | — | — | JP | claimed |
| EP-0738154-A1 | N-TERMINUS MODIFIED ANALOGS OF LHRH | Abbott Laboratories (US) | 1996-10-23 | — | — | EP | claimed |
| JP-H08504209-A | — | — | 1996-05-07 | — | — | JP | claimed |
| EP-0738154-A4 | N-TERMINUS MODIFIED ANALOGS OF LHRH | ABBOTT LAB (US) | 1996-04-12 | — | — | EP | claimed |
| US-5502035-A | N-terminus modified analogs of LHRH | TAP HOLDINGS INC. (US) | 1996-03-26 | — | — | US | claimed |
| EP-0673254-A1 | 6-POSITION MODIFIED DECAPEPTIDE LHRH ANTAGONISTS | ABBOTT LABORATORIES (US) | 1995-09-27 | — | — | EP | claimed |
| WO-1995004540-A1 | N-TERMINUS MODIFIED ANALOGS OF LHRH | ABBOTT LABORATORIES (US) | 1995-02-16 | — | — | WO | claimed |
| WO-1995004541-A1 | N-TERMINUS MODIFIED ANALOGS OF LHRH | ABBOTT LABORATORIES (US) | 1995-02-16 | — | — | WO | claimed |
| WO-1994013313-A1 | 6-POSITION MODIFIED DECAPEPTIDE LHRH ANTAGONISTS | ABBOTT LABORATORIES (US) | 1994-06-23 | — | — | WO | claimed |